Showing 1 to 8 of 8 results
Canada's Pharmacare Rollout Faces Uncertainty as Talks Stall
Following a federal election, the implementation of Canada's Pharmacare Act is facing uncertainty as the federal government has yet to resume talks with several provinces and territories regarding agreements for free access to essential medications and supplies.
Canada's Pharmacare Rollout Faces Uncertainty as Talks Stall
Following a federal election, the implementation of Canada's Pharmacare Act is facing uncertainty as the federal government has yet to resume talks with several provinces and territories regarding agreements for free access to essential medications and supplies.
Progress
28% Bias Score
Lab-Grown Cells Cure Complex Type 1 Diabetes in Clinical Trial
Lab-grown insulin-producing cells successfully cured complex type 1 diabetes in a clinical trial, potentially solving donor shortages and offering a cure for approximately 120,000 patients in the Netherlands, with a new research center in Leiden focusing on broader implementation.
Lab-Grown Cells Cure Complex Type 1 Diabetes in Clinical Trial
Lab-grown insulin-producing cells successfully cured complex type 1 diabetes in a clinical trial, potentially solving donor shortages and offering a cure for approximately 120,000 patients in the Netherlands, with a new research center in Leiden focusing on broader implementation.
Progress
40% Bias Score
Italy First to Offer Weekly Insulin via National Health Service
Italy becomes the first country to offer a new weekly insulin via its National Health Service, reducing annual injections for over 1.3 million insulin-treated patients from 365 to 52, improving quality of life and addressing significant adherence issues.
Italy First to Offer Weekly Insulin via National Health Service
Italy becomes the first country to offer a new weekly insulin via its National Health Service, reducing annual injections for over 1.3 million insulin-treated patients from 365 to 52, improving quality of life and addressing significant adherence issues.
Progress
52% Bias Score
Single Genetic Variation Found to Protect Against Type 1 Diabetes
Dutch researchers discovered a single-letter genetic variation protecting against type 1 diabetes, affecting 100,000 people in the Netherlands; this discovery, published in Cell, enables more precise diagnoses, improved disease prediction, and potential new treatments.
Single Genetic Variation Found to Protect Against Type 1 Diabetes
Dutch researchers discovered a single-letter genetic variation protecting against type 1 diabetes, affecting 100,000 people in the Netherlands; this discovery, published in Cell, enables more precise diagnoses, improved disease prediction, and potential new treatments.
Progress
28% Bias Score
Ginger Shows Promise in Type 2 Diabetes Management
A study suggests ginger supplements may significantly lower blood glucose levels in type 2 diabetes patients, potentially reducing risks of heart disease, kidney failure, and stroke, prompting calls for further research into optimal dosage and dietary incorporation.
Ginger Shows Promise in Type 2 Diabetes Management
A study suggests ginger supplements may significantly lower blood glucose levels in type 2 diabetes patients, potentially reducing risks of heart disease, kidney failure, and stroke, prompting calls for further research into optimal dosage and dietary incorporation.
Progress
52% Bias Score
Nurse's Murder Conviction Upheld in Appeal
Colin Campbell, a nurse convicted of murdering four elderly patients and attempting to murder a fifth by injecting insulin in Leeds hospitals in 2002, lost his appeal on Thursday; the Court of Appeal deemed new evidence insufficient to overturn his convictions.
Nurse's Murder Conviction Upheld in Appeal
Colin Campbell, a nurse convicted of murdering four elderly patients and attempting to murder a fifth by injecting insulin in Leeds hospitals in 2002, lost his appeal on Thursday; the Court of Appeal deemed new evidence insufficient to overturn his convictions.
Progress
48% Bias Score
ATTD 2025: Diabetes Technology Advancements and Access Concerns
The ATTD 2025 conference in Amsterdam (March 19-22) showcased advancements in diabetes treatments and technology, including stem-cell based beta-cell replacement therapies and GLP-1/harmine combinations for beta-cell regeneration, alongside concerns about unequal access to these technologies and the...
ATTD 2025: Diabetes Technology Advancements and Access Concerns
The ATTD 2025 conference in Amsterdam (March 19-22) showcased advancements in diabetes treatments and technology, including stem-cell based beta-cell replacement therapies and GLP-1/harmine combinations for beta-cell regeneration, alongside concerns about unequal access to these technologies and the...
Progress
56% Bias Score
California's Affordable Insulin Plan Faces Delays
California's plan to produce cheap insulin by 2024 is delayed due to the time needed for clinical trials and FDA approval, impacting 3.2 million diabetics and exceeding the projected timeline by at least one year.
California's Affordable Insulin Plan Faces Delays
California's plan to produce cheap insulin by 2024 is delayed due to the time needed for clinical trials and FDA approval, impacting 3.2 million diabetics and exceeding the projected timeline by at least one year.
Progress
44% Bias Score
Showing 1 to 8 of 8 results